Page last updated: 2024-09-05

sb 203580 and allantoin

sb 203580 has been researched along with allantoin in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (allantoin)	Trials (allantoin)	Recent Studies (post-2010) (allantoin)
3,489	4	1,137	1,130	70	257

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breier, G; Clauss, M; Drexler, HC; Gaumann, A; Hippenstiel, S; Issbrücker, K; Marti, HH; Springmann, G; Suttorp, N; Voswinckel, R	1

Other Studies

1 other study(ies) available for sb 203580 and allantoin

Article	Year
p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:2 Topics: Allantoin; Animals; Capillary Permeability; Cell Survival; Chick Embryo; Chorion; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Fibroblast Growth Factor 2; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plasminogen; Pyridines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003

Article

Year

p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:2

Topics: Allantoin; Animals; Capillary Permeability; Cell Survival; Chick Embryo; Chorion; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Fibroblast Growth Factor 2; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plasminogen; Pyridines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003